Cryo-Cell International, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CCEL | NIVF | 0H9X.IL | CTE.AX | BLFS | CELU | |
|---|---|---|---|---|---|---|
| Market cap | 40.88M | 6.85M | 14.81B | 59.55M | — | 26.25M |
| P/E (TTM) | — | — | 20.2 | 30.5 | — | — |
| Forward P/E | 253.5 | 0.0 | — | 19.7 | — | -1.4 |
| Price/book | -2.5 | 0.0 | 0.9 | 12.3 | — | -0.7 |
| Dividend yield | — | — | 3.38% | — | — | — |
| 1-year change | +15.30% | −99.99% | −2.24% | +2.52% | — | −52.13% |
| Today | +0.40% | −17.56% | −0.45% | 0.00% | 0.00% | −1.02% |
The closest companies by business and industry (Medical Care Facilities). Prices may be delayed up to 20 min.
Latest news
All CCEL news ›CRYO CELL INTERNATIONAL 3Q FY2026: Revenue $7.82M, 10-Q Summary
TradingView CRYO CELL INTERNATIONAL 3Q FY2026: Revenue $7.82M, 10-Q Summary CRYO CELL INTERNATIONAL INC reported third-quarter fiscal 2026 revenue of $7.82M, essentially flat with $7.83M in the year-ago quarter, as modest growth in rec
Cryo-Cell International Q3 net income, EPS rise
TradingView Cryo-Cell International Q3 net income, EPS rise
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- tradingview.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.